Results 51 to 60 of about 1,865 (185)
Surgical strategy in lithium‐associated hyperparathyroidism: A population‐based study
World Journal of Surgery, Volume 48, Issue 2, Page 408-415, February 2024.Abstract Background The extent of parathyroidectomy (PTX) recommendation in patients with lithium‐associated hyperparathyroidism (LAH) remains controversial. The primary objectives of this study were to analyze extent of surgery, complications, and long‐term outcomes.
I.‐L. Nilsson +5 more
wiley +1 more source
Clinical Physiology and Functional Imaging, Volume 44, Issue 1, Page 79-88, January 2024.Abstract Background A novel semiconductor cadmium zinc telluride (CZT) gamma camera system using a block sequential regularized expectation maximization (BSREM) reconstruction algorithm is now clinically available. Here we investigate how a multi‐purpose ring‐configurated CZT system can be safely applied in clinics and describe the initial optimization
Irma Cerić Andelius +6 more
wiley +1 more source
Alendronate induces anti-migratory effects and inhibition of neutral phosphatases in UMR106 osteosarcoma cells [PDF]
, 2007 Bisphosphonates are nonhydrolysable pyrophosphate analogues that prevent bone loss in several types of cancer. However, the mechanisms of anticancer action of bisphosphonates are not completely known.
Bruzzone, L. +2 more
core +2 more sources
Treatment of calcinosis with biphosphonates in juvenile dermatomyositis [PDF]
Pediatric Rheumatology, 2008 Juvenile dermatomyositis (JDM) is a multisystem disease that is characterized by nonsuppurative inflammation of striated muscle and skin. Dystrophic calcification occurs in up to 40% of children We present our treatment approach in four JDM patients with calcinosis.
Bilginer, Y, Topaloglu, R, Gonc, N
openaire +3 more sources
Skeletal system of the prostate, bladder and kidney tumors, and biphosphonate treatment
Urology Research and Practice, 2019 Genitourinary system tumors are the most common tumors with bone metastases. Bone metastases are observed in advanced prostate, bladder and kidney cancers.
Ferhat Ateş, Kadir Vehbi Baykal
doaj +2 more sources
Balkan Journal of Dental Medicine, 2017 Background: The first cases of bisphosphonate-related osteonecrosis of the jaw (BRONJ) were reported in 2003. Since then number of possible treatments have been proposed.
Anitua Eduardo
doaj +1 more source
A rare case of zolendronate infusion complication leading to glaucoma filtration surgery
Clinical Ophthalmology, 2011 A Khan1, G Lascaratos1, T Rane-Malcolm2, R Sanders21Princess Alexandra Eye Pavilion, Edinburgh, 2Department of Ophthalmology, Queen Margaret Hospital, Dunfermline, Fife, UKAbstract: Zolendronic acid is a nitrogenous biphosphonate commonly used as an ...
Khan A +3 more
doaj
Anales de medicina interna (Madrid, Spain : 1984), 2006 Biophosphonates are analogues of pyrophosphate. The mechanism of action of bisphosphates is the inhibition of osteoclast activation (antiresorptive mechanism). The oral bioavailability of biophosphonates is only about 1-2%, and because of gastrointestinal side effects (mainly esophageal irritation), oral agents are less useful in oncology ...
P, Khosravi Shahi +1 more
openaire +1 more source
Biphosphonates-related osteonecrosis of the jaw
Medical Research Journal, 2019 The relationship between osteonecrosis of the jaw and bisphosphonate therapy has been described recently. Although bisphosphonates have a long list of benefits in the treatment of patients with bone metastases, an increasing number of reports describe the complication of bisphosphonate-related osteonecrosis of the jaw (BRONJ).
Katarzyna Białożyk-Mularska +1 more
openaire +2 more sources
The survey of anti-inflammatory effect of bisphosphonates
Journal of Mazandaran University of Medical Sciences, 2009 (Received 13 Dec, 2008 ; Accepted 28 Jan, 2009)AbstractBisphosphonates are currently used in metabolic disorder of bone; however, there have been few studies that reviewed the role of anti-inflammatory and immune modulatory effect of this agent in in ...
Reza Shiari +3 more
doaj